COMP <GO>
CAPR vs ALT // EV/EBITDA & P/E VALUATION
Capricor Therapeutics Inc. (NASDAQ) VS. Altimmune Inc. (NASDAQ) • 15-METRIC TALLY: CAPR 2
— ALT 4
■ METRIC PARITY
LAST: $6.63 (+6.42%) • MKT CAP: $385.5M
valuation
—
LAST: $2.14 (+1.91%) • MKT CAP: $416.3M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CAPR VS. ALT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CAPR | ALT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -34.70% | -0.30 | ALT | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -18.86% | -16.23% | -2.63 | ALT | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 105.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.38 | 1.30 | +2.08 | CAPR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 5/9 | -3.00 | ALT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.6 | 26.7 | +14.93 | CAPR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $385.5M | $416.3M | -$30.8M | ALT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CAPR REV | ALT REV | CAPR GROSS % | ALT GROSS % | CAPR FCF | ALT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $41.0K | — | — | -$72.7M | -$67.5M |
| FY 2024 | $22.3M | $20.0K | — | — | -$41.2M | -$79.8M |
| FY 2023 | $25.2M | $426.0K | — | — | -$25.6M | -$75.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CAPR // BETA —
ALT // BETA —